Hyblate Medical

Company Overview

Snapshot

Founded in June 2018 by Liron Tayeb, Mahmoud Suleiman, and Lior Gepstein, Hyblate Medical operated with 1–10 employees. The company developed an efficient ablation catheter to treat atrial fibrillation, a technology that emerged from a collaboration with Rambam MedTech in June 2018.

Business overview

Hyblate Medical developed the Hyblate catheter, a medical device designed to treat atrial fibrillation (irregular heartbeat). The company's core technology combines the advantages of two existing ablation methods into a hybrid catheter, incorporating effective control mechanisms to offer a safe and effective treatment. Hyblate Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving the global healthcare market.

Company Intelligence Q&A

What is Hyblate Medical's primary focus?

Hyblate Medical is focused on developing a hybrid catheter to treat atrial fibrillation, an irregular heartbeat condition, by combining existing ablation methods into a single device.

When was Hyblate Medical founded?

Hyblate Medical was founded in June 2018.

Who are the founders of Hyblate Medical?

The co-founders of Hyblate Medical are Liron Tayeb, Mahmoud Suleiman, and Lior Gepstein.

What was a key technological milestone for Hyblate Medical?

In June 2018, Hyblate Medical developed an efficient ablation catheter to treat atrial fibrillation, leveraging technology from Rambam MedTech.

What is the operational status of Hyblate Medical?

Hyblate Medical is non-active and ceased to operate in February 2023.